136 related articles for article (PubMed ID: 37927021)
1. [Effect of Calcification on the Ultrasound-Guided Radiofrequency Ablation of Papillary Thyroid Carcinoma].
Li YM; Yan L; Xiao J; Zhang MB; Luo YK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):803-808. PubMed ID: 37927021
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Outcomes and Risk Factors of Radiofrequency Ablation for T1N0M0 Papillary Thyroid Carcinoma.
Li X; Yan L; Xiao J; Li Y; Yang Z; Zhang M; Luo Y
JAMA Surg; 2024 Jan; 159(1):51-58. PubMed ID: 37878294
[TBL] [Abstract][Full Text] [Related]
3. Comparison of ultrasound-guided radiofrequency ablation versus thyroid lobectomy for T1bN0M0 papillary thyroid carcinoma.
Yan L; Li X; Li Y; Xiao J; Zhang M; Luo Y
Eur Radiol; 2023 Jan; 33(1):730-740. PubMed ID: 35895122
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
Yan L; Li Y; Li XY; Xiao J; Tang J; Luo Y
Cancer; 2023 Aug; 129(16):2469-2478. PubMed ID: 37060239
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma in the danger triangle area: a preliminary analysis.
Zhang DL; Chen S; Qiu Y; Yang JC; Hong Z; Li J; Wu SS
Int J Hyperthermia; 2024; 41(1):2305256. PubMed ID: 38314684
[TBL] [Abstract][Full Text] [Related]
6. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer.
Chung SR; Baek JH; Choi YJ; Lee JH
Eur Radiol; 2019 Sep; 29(9):4897-4903. PubMed ID: 30805701
[TBL] [Abstract][Full Text] [Related]
7. Ultrasonography-guided radiofrequency ablation for solitary T1aN0M0 and T1bN0M0 papillary thyroid carcinoma: a retrospective comparative study.
Xiao J; Zhang Y; Yan L; Zhang M; Li X; Tang J; Luo Y
Eur J Endocrinol; 2021 Dec; 186(1):105-113. PubMed ID: 34757942
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-Guided Radiofrequency Ablation
He H; Wu R; Zhao J; Song Q; Zhang Y; Luo Y
Front Endocrinol (Lausanne); 2021; 12():734432. PubMed ID: 34512557
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of matrix metalloproteinase-2 and -9 in ultrasound-guided radiofrequency ablation treatment for papillary thyroid carcinoma.
Pan Q; Yuan T; Ding Q
J Int Med Res; 2020 Aug; 48(8):300060520917581. PubMed ID: 32772889
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of radiofrequency ablation for locally recurrent papillary thyroid carcinoma.
Yang Z; Yan L; Xiao J; Li W; Li X; Li Y; Zhang M; Luo Y
Int J Hyperthermia; 2023; 40(1):2191912. PubMed ID: 37164353
[TBL] [Abstract][Full Text] [Related]
11. [Validated Nomogram Predicting Clinical Outcome after Radiofrequency Ablation in the Treatment of Papillary Thyroid Microcarcinoma].
He HY; Luo YK; Zhang Y; Song Q; Li W; Zhao JH; Li Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Jun; 43(3):322-327. PubMed ID: 34238406
[TBL] [Abstract][Full Text] [Related]
12. Surgery After Ultrasound-Guided Radiofrequency Ablation for Papillary Thyroid Carcinoma in 21 Patients: A Retrospective Study from a Single Center in China.
Sun W; Zhang H; He L; Zhang T; Wang Z; Dong W; Jiang Y
Med Sci Monit; 2020 Nov; 26():e928391. PubMed ID: 33221812
[TBL] [Abstract][Full Text] [Related]
13. Optimal thyrotropin level for low-risk papillary thyroid carcinoma after ultrasound-guided radiofrequency ablation.
Li X; Yan L; Xiao J; Li Y; Zhu Y; Yang Z; Zhang M; Luo Y
Int J Hyperthermia; 2023; 40(1):2160880. PubMed ID: 36599433
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound-Guided Radiofrequency Ablation Versus Surgery for Low-Risk Papillary Thyroid Microcarcinoma: Results of Over 5 Years' Follow-Up.
Zhang M; Tufano RP; Russell JO; Zhang Y; Zhang Y; Qiao Z; Luo Y
Thyroid; 2020 Mar; 30(3):408-417. PubMed ID: 31910107
[No Abstract] [Full Text] [Related]
15. Long-Term Follow-Up Results of Ultrasound-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: More Than 5-Year Follow-Up for 84 Tumors.
Cho SJ; Baek SM; Lim HK; Lee KD; Son JM; Baek JH
Thyroid; 2020 Dec; 30(12):1745-1751. PubMed ID: 32375570
[No Abstract] [Full Text] [Related]
16. Sonographic Evolution and Pathologic Findings of Papillary Thyroid Cancer After Radiofrequency Ablation: A Five-Year Retrospective Cohort Study.
Li X; Li Y; Yan L; Xiao J; Yang Z; Jing H; Zhang M; Luo Y
Thyroid; 2024 Jan; 34(1):54-63. PubMed ID: 37885207
[No Abstract] [Full Text] [Related]
17. [Short-term Outcome of T1bN0M0 Papillary Thyroid Cancer after Ultrasonography-guided Radiofrequency Ablation].
Xiao J; Lan Y; Yan L; Zhang MB; Zhang Y; Xie F; Song Q; Luo YK; Tang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Dec; 42(6):771-775. PubMed ID: 33423724
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Ultrasound-Guided Radiofrequency Ablation as a Treatment Option for Papillary Thyroid Microcarcinoma in the Isthmus: A Retrospective Study.
Song Q; Gao H; Tian X; Ren L; Lan Y; Yan L; Luo Y
Front Endocrinol (Lausanne); 2020; 11():599471. PubMed ID: 33633683
[TBL] [Abstract][Full Text] [Related]
19. Nomogram prediction for the involution of the ablation zone after radiofrequency ablation treatment in patients with low-risk papillary thyroid carcinoma.
He H; Zhang Y; Song Q; Zhao J; Li W; Li Y; Luo Y
Int J Hyperthermia; 2021; 38(1):1133-1139. PubMed ID: 34348562
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonography-guided radiofrequency ablation for the treatment of T2N0M0 papillary thyroid carcinoma: a preliminary study.
Xiao J; Zhang Y; Zhang M; Xie F; Yan L; Luo Y; Tang J
Int J Hyperthermia; 2021; 38(1):402-408. PubMed ID: 33719861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
